[cancerpage is a service of Alere]
 


[home]
[search the site]
[my cancerpage]
[ribbon project]
[stories and experiences]
[glossary of terms]
[journal of hope]
[comments]
[about us]
[policies and disclaimers]
[physician and service directories]

No Bowel Cleansing Needed With Investigative Screening Technique

NEW YORK AUG 14, 2007 (Reuters Health) - Magnetic resonance (MR) colonography, which uses fecal tagging to avoid the need for bowel cleansing, is accurate in detecting adenomatous lesions at risk for becoming cancer, new research indicates.

However, further refinements to improve the image quality of tagging are needed as many colonic segments could not be evaluated. Moreover, improvements are needed to better detect lesions <5 mm in diameters, according to the report in the August issue of Gut.

The findings stem from a study of 315 adults older than 50 years who underwent screening. A tagging agent solution (5% Gastrografin, 1% barium and 0.2% locust bean gum) was ingested 2 days before MR colonography.

No bowel cleansing agents were given, although rectal water enema was administered during imaging for bowel distension. No sedative or analgesic medications were given.

The findings on MR colonography were compared with those obtained with conventional colonoscopy, the report indicates.

Dr. Christiane A. Kuehle, from University Hospital Essen in Germany, and colleagues found that 4% of colonic segments had poor image quality due to the presence of untagged fecal material.

Overall, MR colonography was 83.0% sensitive in detecting adenomatous polyps >5 mm. By contrast, just 16 of 153 lesions <5 mm were detected with this modality as were just 9 of 127 hyperplastic polyps. The overall specificity of MR colonography was 90.2%.

"Because of the high diagnostic accuracy and the possibility of simultaneous polypectomy, conventional colonoscopy will keep on playing a leading role as a screening tool," the authors conclude. "However, for patients unwilling to undergo colonoscopy, MR colonography should be regarded as an attractive alternative."

SOURCE:




"Reuters content is the intellectual property of Reuters Limited. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon."
 

 MedlinePlus is a resource for health information offered to the public by the US Government. The search box below will direct you to publicly available health information from the National Institutes of Health, the FDA and other government agencies.
Search MEDLINEplus:
 

MEDLINEplus en español

 
We subscribe to the HONcode principles of the Health On the Net Foundation


cancerpage.com 2000
- 2009 . Please send your feedback, comments and suggestions to our staff. Read our policies and terms of service . cancerpage.com is a service of Alere® .
© (2009) Inverness Medical. All Rights Reserved. Alere is a trademark of the Inverness Medical group of companies.